Preclinical Services for HIV Therapeutics

A competitive multiple award, Indefinite Delivery/Indefinite Quantity (IDIQ) type contract was awarded, as a total small business set-aside, with a seven year ordering period (October 15, 2020 through October 14, 2027).  It is anticipated that Task Orders issued against these contracts will most likely be cost-reimbursement, term/completion type Task Orders.  Upon analysis of the type of work and all associated costs involved, fixed-price type task orders are usually not feasible due to the absence of precise specifications and difficulties in estimating costs with accuracy.  Based upon the uncertainties involved, the Government would assume undue risk in attempting to fit relatively dynamic (science responsive and result-driven) requirement into a fixed-price environment. In these instances, fixed-price task orders would be disadvantageous to the Government, since they do not provide the Government with the flexibility that is needed to responsively and responsibly shift with the evolving needs of this requirement.  However, fixed-price Task Orders may be issued, where appropriate and feasible.

The Contractor is eligible for Task Orders under Task Areas A, B, and E (Task Area B is a total small business set-aside).

The award notice is in relation to Solicitation # 75N93019R00021, which was posted on https://beta.sam.gov. 
 

Awarded contract 75N93021D00002 to ALCHEM LABORATORIES CORP for 107274471.00 on 2020-10-15.